The Epstein-Barr (EBV) test is used for the qualitative detection of IgG antibodies against the Epstein-Barr virus (EBV), specifically targeting the viral capsid antigen (VCA) and Epstein-Barr nuclear antigen (EBNA) in blood samples. The test can indicate previous exposure or an ongoing infection. Results are available within approximately 15 minutes.

The Epstein-Barr virus (EBV) is a common human virus belonging to the herpesvirus family. It is best known for causing infectious mononucleosis, often referred to as glandular fever. Most people are infected with EBV at some point in their lives, and the virus can remain latent in the body for many years.
A primary EBV infection may cause symptoms such as fever, swollen lymph nodes, fatigue, sore throat, and sometimes an enlarged spleen. The severity of symptoms varies, but they are most commonly seen in teenagers and young adults.
The Epstein-Barr (EBV) test is used for the qualitative detection of IgG antibodies against EBV’s Viral Capsid Antigen (VCA) and Epstein-Barr Nuclear Antigen (EBNA) in blood samples. The analysis provides information about previous exposure or an ongoing infection. The test is performed using capillary or venous blood and delivers results within approximately 15 minutes.
The EBV test can help differentiate an EBV infection from other conditions with similar clinical presentations, such as infections caused by cytomegalovirus or Toxoplasma gondii.
The test is CE-marked and intended for professional use within healthcare settings.
No reviews available
